 to ASA was studied in 851
patients in the Clopidogrel and Acetylsalicylic Acid In Bypass
Surgery for Peripheral Arterial Disease Trial (CASPAR).237
This placebo-controlled RCT found no difference in outcome
between patients receiving ASA vs ASA plus clopidogrel undergoing lower extremity bypass. However, the subset of

patients undergoing prosthetic bypass (30%), demonstrated
improved patency and limb salvage when receiving